PROCEPT BioRobotics Operating Margin 2021-2024 | PRCT
Current and historical operating margin for PROCEPT BioRobotics (PRCT) over the last 10 years. The current operating profit margin for PROCEPT BioRobotics as of December 31, 2024 is -36.20%.
| PROCEPT BioRobotics Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-12-31 | $0.22B | $-0.10B | -43.30% |
| 2024-09-30 | $0.20B | $-0.11B | -53.50% |
| 2024-06-30 | $0.18B | $-0.11B | -62.71% |
| 2024-03-31 | $0.16B | $-0.11B | -70.06% |
| 2023-12-31 | $0.14B | $-0.11B | -80.88% |
| 2023-09-30 | $0.12B | $-0.11B | -90.52% |
| 2023-06-30 | $0.10B | $-0.10B | -100.00% |
| 2023-03-31 | $0.09B | $-0.09B | -109.41% |
| 2022-12-31 | $0.08B | $-0.08B | -108.00% |
| 2022-09-30 | $0.06B | $-0.07B | -119.67% |
| 2022-06-30 | $0.05B | $-0.06B | -128.00% |
| 2022-03-31 | $0.04B | $-0.06B | -143.90% |
| 2021-12-31 | $0.03B | $-0.05B | -158.82% |
| 2021-06-30 | $0.02B | $-0.04B | -205.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $3.077B | $0.225B |
| PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif. | |||